Minimum Dose CT Post Lung Biopsy

University Health Network, Toronto

Status and phase: Completed; Phase 1

Conditions: Lung Cancer

Treatments: Device: CT

Study type: Interventional

Funder types: Other

Identifiers

NCT00188162

03-0898

Details and patient eligibility

About

The aim is to evaluate whether Minimum Dose CT (MnDCT) is useful in the management of patients post Lung Biopsy

Full description

Patients post Lung Biopsy have a chest X-ray (CXR) and a MnDCT post lung biopsy. Both studies are compared for the detection of a pneumothorax

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All Patients having a lung biopsy

Exclusion criteria

• None

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)